Abstract
Enzymes play a vital role in the biological system as a catalyst for biochemical reactions. They have a wide range of commercial applications in many areas like the pharmaceutical industry, food industry, etc. l-asparaginase is one of the commercial enzymes with prime importance in anticancer therapy. It is mainly used in chemotherapy; however, it has the potential to cure autoimmune disorders and infectious diseases also. Previous studies reported the antimicrobial potential of l-asparaginase. Therefore, we have discussed the possibility and challenges of the antimicrobial application of l-asparaginase in the treatment of infectious diseases. This is followed by a discussion on the effective delivery of this enzyme using biopolymeric nanocarriers that ensure safe and on target action. The present article gives a perspective on the l-asparaginase molecule that could be developed/established as an approved antimicrobial drug in the future.
Author supplied keywords
Cite
CITATION STYLE
Vimal, A., & Kumar, A. (2022, January 1). l-asparaginase: Need for an Expedition from an Enzymatic Molecule to Antimicrobial Drug. International Journal of Peptide Research and Therapeutics. Springer Science and Business Media B.V. https://doi.org/10.1007/s10989-021-10312-x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.